Skip to Main Content

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria


Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | Diseases of the Kidney & Urinary Tract

Phase III

What is the purpose of this trial?

Brief Summary:

The purpose of this study is to determine the efficacy and safety of ALLN-177 in patients with enteric hyperoxaluria

  • Trial with
    Allena Pharmaceuticals, Inc.
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC